CHARACTERISTIC CLINICOPATHOLOGICAL FEATURES OF ADULT B-CELL LYMPHOBLASTIC LYMPHOMA WITH SPECIAL EMPHASIS ON DIFFERENTIAL-DIAGNOSIS WITH AN ATYPICAL FORM PROBABLY OF BLASTIC LYMPHOCYTIC LYMPHOMA OF INTERMEDIATEDIFFERENTIATION ORIGIN
Al. Cheng et al., CHARACTERISTIC CLINICOPATHOLOGICAL FEATURES OF ADULT B-CELL LYMPHOBLASTIC LYMPHOMA WITH SPECIAL EMPHASIS ON DIFFERENTIAL-DIAGNOSIS WITH AN ATYPICAL FORM PROBABLY OF BLASTIC LYMPHOCYTIC LYMPHOMA OF INTERMEDIATEDIFFERENTIATION ORIGIN, Cancer, 73(3), 1994, pp. 706-710
Background. Lymphoblastic lymphoma is typically of thymic T-cell pheno
type. Lymphoblastic lymphoma of B-cell origin (B-lymphoblastic lymphom
a) has been relatively poorly described. Whether B-lymphoblastic lymph
oma should be managed like its T-cell counterpart remains to be clarif
ied. Methods. From 1933 to 1991, 10 adult patients were diagnosed as h
aving B-lymphoblastic lymphoma at National Taiwan University Hospital
by using the histomorphologic criteria of international working formul
ation. B-cell phenotype was determined by the immunohistochemistry met
hod. Clinicopathologic features of these 10 patients were reviewed. Re
sults. Seven patients were grouped as typical type and were characteri
zed by an aggressive clinical course with lymph node (7 of 7), bone ma
rrow (6 of 7), liver (3 of 7), spleen (3 of 7), and central nervous sy
stem (2 of 7) involvement. The median survival time was 8 months. In c
ontrast, three patients had an atypical clinical picture. They were ol
der patients (64-73 years) and were characterized by a relatively less
aggressive course with predominantly bulky nodal involvement. Two of
these three patients are alive (31 and 49 months, respectively) and we
ll at this report, with one of them being repeatedly experiencing dise
ase remission with the use of simple salvage chemotherapeutic regimens
. Further studies revealed that tumor tissues of these three atypical
cases had strong expression of CD5 (Leu-1) marker. Conclusion. B-lymph
oblastic lymphoma diagnosed by histomorphologic criteria should be fur
ther distinguished from a relatively favorable subtype, which probably
represents a variant of blastic lymphocytic lymphoma of intermediate
differentiation as described by Lardelli et al.(1) Clinical features o
f typical B-lymphoblastic lymphoma, except for the lack of mediastinal
involvement, is similar to its T-cell counterpart.